Quantitative Proteomics Identifies Serum Response Factor Binding Protein 1 as a Host Factor for Hepatitis C Virus Entry

Cell Reports

Volumn 12, Issue 5, 2015, Pages 864-878

  Gerold, Gisa ^a,b   Meissner, Felix ^c   Bruening, Janina ^a   Welsch, Kathrin ^a   Perin, Paula M ^a   Baumert, Thomas F ^d   Vondran, Florian W ^e   Kaderali, Lars ^f   Marcotrigiano, Joseph ^g   Khan, Abdul G ^g   Mann, Matthias ^c   Rice, Charles M ^b   Pietschmann, Thomas ^a  

^a INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^b ROCKEFELLER UNIVERSITY   (United States)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^g RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOST FACTOR; PROTEIN CD81; PROTEIN SRFBP1; UNCLASSIFIED DRUG; VIRUS RECEPTOR; VIRUS RNA; SRFBP1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; CORONAVIRIDAE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEOMICS; QUANTITATIVE ANALYSIS; RNA INTERFERENCE; VESICULOVIRUS; VIRUS CELL INTERACTION; VIRUS ENTRY; HEPACIVIRUS; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

CORONAVIRUS; HEPATITIS C VIRUS; VESICULAR STOMATITIS VIRUS;

CELL LINE, TUMOR; HEPACIVIRUS; HUMANS; PROTEOMICS; TRANSCRIPTION FACTORS; VIRUS INTERNALIZATION;

EID: 84938549709     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.06.063     Document Type: Article

References (57)

1. Benali-Furet N.L., Chami M., Houel L., De Giorgi F., Vernejoul F., Lagorce D., Buscail L., Bartenschlager R., Ichas F., Rizzuto R., Paterlini-Bréchot P. Hepatitis C virus core triggers apoptosis in liver cells by inducing ER stress and ER calcium depletion. Oncogene 2005, 24:4921-4933.
2. Berger K.L., Cooper J.D., Heaton N.S., Yoon R., Oakland T.E., Jordan T.X., Mateu G., Grakoui A., Randall G. Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication. Proc. Natl. Acad. Sci. USA 2009, 106:7577-7582.
3. Blanchard E., Belouzard S., Goueslain L., Wakita T., Dubuisson J., Wychowski C., Rouillé Y. Hepatitis C virus entry depends on clathrin-mediated endocytosis. J. Virol. 2006, 80:6964-6972.
4. Brazzoli M., Bianchi A., Filippini S., Weiner A., Zhu Q., Pizza M., Crotta S. CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes. J. Virol. 2008, 82:8316-8329.
5. Brimacombe C.L., Wilson G.K., Hübscher S.G., McKeating J.A., Farquhar M.J. A role for CD81 and hepatitis C virus in hepatoma mobility. Viruses 2014, 6:1454-1472.
6. Chang K.S., Jiang J., Cai Z., Luo G. Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture. J. Virol. 2007, 81:13783-13793.
7. Charrin S., Le Naour F., Labas V., Billard M., Le Caer J.P., Emile J.F., Petit M.A., Boucheix C., Rubinstein E. EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells. Biochem. J. 2003, 373:409-421.
8. Chen H., Engelman A. The barrier-to-autointegration protein is a host factor for HIV type 1 integration. Proc. Natl. Acad. Sci. USA 1998, 95:15270-15274.
9. Coller K.E., Berger K.L., Heaton N.S., Cooper J.D., Yoon R., Randall G. RNA interference and single particle tracking analysis of hepatitis C virus endocytosis. PLoS Pathog. 2009, 5:e1000702.
10. Cox J., Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 2008, 26:1367-1372.
11. Cox J., Mann M. 1D and 2D annotation enrichment: a statistical method integrating quantitative proteomics with complementary high-throughput data. BMC Bioinformatics 2012, 13(16):S12.
12. de Chassey B., Meyniel-Schicklin L., Aublin-Gex A., André P., Lotteau V. New horizons for antiviral drug discovery from virus-host protein interaction networks. Curr Opin Virol 2012, 2:606-613.
13. Diao J., Pantua H., Ngu H., Komuves L., Diehl L., Schaefer G., Kapadia S.B. Hepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry. J. Virol. 2012, 86:10935-10949.
14. Dziduszko A., Ozbun M.A. Annexin A2 and S100A10 regulate human papillomavirus type 16 entry and intracellular trafficking in human keratinocytes. J. Virol. 2013, 87:7502-7515.
15. Evans M.J., von Hahn T., Tscherne D.M., Syder A.J., Panis M., Wölk B., Hatziioannou T., McKeating J.A., Bieniasz P.D., Rice C.M. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 2007, 446:801-805.
16. Farquhar M.J., Hu K., Harris H.J., Davis C., Brimacombe C.L., Fletcher S.J., Baumert T.F., Rappoport J.Z., Balfe P., McKeating J.A. Hepatitis C virus induces CD81 and claudin-1 endocytosis. J. Virol. 2012, 86:4305-4316.
17. Gautier R., Douguet D., Antonny B., Drin G. HELIQUEST: a web server to screen sequences with specific α-helical properties. Bioinformatics 2008, 24:2101-2102.
18. Gerold G., Pietschmann T. The HCV life cycle: in vitro tissue culture systems and therapeutic targets. Dig. Dis. 2014, 32:525-537.
19. Gerold G., Rice C.M. Locking out hepatitis C. Nat. Med. 2011, 17:542-544.
20. Gravitz L. Introduction: a smouldering public-health crisis. Nature 2011, 474:S2-S4.
21. Harris H.J., Clerte C., Farquhar M.J., Goodall M., Hu K., Rassam P., Dosset P., Wilson G.K., Balfe P., Ijzendoorn S.C., et al. Hepatoma polarization limits CD81 and hepatitis C virus dynamics. Cell. Microbiol. 2013, 15:430-445.
22. Hsu M., Zhang J., Flint M., Logvinoff C., Cheng-Mayer C., Rice C.M., McKeating J.A. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc. Natl. Acad. Sci. USA 2003, 100:7271-7276.
23. Ibrahim N., Wicklund A., Wiebe M.S. Molecular characterization of the host defense activity of the barrier to autointegration factor against vaccinia virus. J. Virol. 2011, 85:11588-11600.
24. Keilhauer E.C., Hein M.Y., Mann M. Accurate protein complex retrieval by affinity enrichment mass spectrometry (AE-MS) rather than affinity purification mass spectrometry (AP-MS). Mol. Cell. Proteomics 2015, 14:120-135.
25. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin. Microbiol. Infect. 2011, 17:107-115.
26. Law G.L., Korth M.J., Benecke A.G., Katze M.G. Systems virology: host-directed approaches to viral pathogenesis and drug targeting. Nat. Rev. Microbiol. 2013, 11:455-466.
27. Lisinski I., Matsumoto H., Yver D.R., Schürmann A., Cushman S.W., Al-Hasani H. Identification and characterization of p49/STRAP as a novel GLUT4-binding protein. Biochem. Biophys. Res. Commun. 2006, 344:1179-1185.
28. Lupberger J., Zeisel M.B., Xiao F., Thumann C., Fofana I., Zona L., Davis C., Mee C.J., Turek M., Gorke S., et al. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat. Med. 2011, 17:589-595.
29. Ma G., Greenwell-Wild T., Lei K., Jin W., Swisher J., Hardegen N., Wild C.T., Wahl S.M. Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection. J. Exp. Med. 2004, 200:1337-1346.
30. Malhotra R., Ward M., Bright H., Priest R., Foster M.R., Hurle M., Blair E., Bird M. Isolation and characterisation of potential respiratory syncytial virus receptor(s) on epithelial cells. Microbes Infect. 2003, 5:123-133.
31. Meissner F., Mann M. Quantitative shotgun proteomics: considerations for a high-quality workflow in immunology. Nat. Immunol. 2014, 15:112-117.
32. Mercer J., Schelhaas M., Helenius A. Virus entry by endocytosis. Annu. Rev. Biochem. 2010, 79:803-833.
33. Montpellier C., Tews B.A., Poitrimole J., Rocha-Perugini V., D'Arienzo V., Potel J., Zhang X.A., Rubinstein E., Dubuisson J., Cocquerel L. Interacting regions of CD81 and two of its partners, EWI-2 and EWI-2wint, and their effect on hepatitis C virus infection. J. Biol. Chem. 2011, 286:13954-13965.
34. Muthumani K., Choo A.Y., Zong W.X., Madesh M., Hwang D.S., Premkumar A., Thieu K.P., Emmanuel J., Kumar S., Thompson C.B., Weiner D.B. The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1. Nat. Cell Biol. 2006, 8:170-179.
35. Nielsen E., Severin F., Backer J.M., Hyman A.A., Zerial M. Rab5 regulates motility of early endosomes on microtubules. Nat. Cell Biol. 1999, 1:376-382.
36. Olson E.N., Nordheim A. Linking actin dynamics and gene transcription to drive cellular motile functions. Nat. Rev. Mol. Cell Biol. 2010, 11:353-365.
37. Ong S.E., Blagoev B., Kratchmarova I., Kristensen D.B., Steen H., Pandey A., Mann M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1:376-386.
38. Orchard S., Ammari M., Aranda B., Breuza L., Briganti L., Broackes-Carter F., Campbell N.H., Chavali G., Chen C., del-Toro N., et al. The MIntAct project-IntAct as a common curation platform for 11 molecular interaction databases. Nucleic Acids Res. 2014, 42:D358-D363.
39. Park E., Griffin D.E. Interaction of Sindbis virus non-structural protein 3 with poly(ADP-ribose) polymerase 1 in neuronal cells. J. Gen. Virol. 2009, 90:2073-2080.
40. Piccoli C., Quarato G., Ripoli M., D'Aprile A., Scrima R., Cela O., Boffoli D., Moradpour D., Capitanio N. HCV infection induces mitochondrial bioenergetic unbalance: causes and effects. Biochim. Biophys. Acta 2009, 1787:539-546.
41. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., Weiner A.J., Houghton M., Rosa D., Grandi G., Abrignani S. Binding of hepatitis C virus to CD81. Science 1998, 282:938-941.
42. Ploss A., Evans M.J., Gaysinskaya V.A., Panis M., You H., de Jong Y.P., Rice C.M. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 2009, 457:882-886.
43. Rajesh S., Sridhar P., Tews B.A., Fénéant L., Cocquerel L., Ward D.G., Berditchevski F., Overduin M. Structural basis of ligand interactions of the large extracellular domain of tetraspanin CD81. J. Virol. 2012, 86:9606-9616.
44. Raynor C.M., Wright J.F., Waisman D.M., Pryzdial E.L. Annexin II enhances cytomegalovirus binding and fusion to phospholipid membranes. Biochemistry 1999, 38:5089-5095.
45. Reiss S., Rebhan I., Backes P., Romero-Brey I., Erfle H., Matula P., Kaderali L., Poenisch M., Blankenburg H., Hiet M.S., et al. Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Cell Host Microbe 2011, 9:32-45.
46. Rieber N., Knapp B., Eils R., Kaderali L. RNAither, an automated pipeline for the statistical analysis of high-throughput RNAi screens. Bioinformatics 2009, 25:678-679.
47. Sainz B., Barretto N., Martin D.N., Hiraga N., Imamura M., Hussain S., Marsh K.A., Yu X., Chayama K., Alrefai W.A., Uprichard S.L. Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nat. Med. 2012, 18:281-285.
48. Sapay N., Guermeur Y., Deléage G. Prediction of amphipathic in-plane membrane anchors in monotopic proteins using a SVM classifier. BMC Bioinformatics 2006, 7:255.
49. Scarselli E., Ansuini H., Cerino R., Roccasecca R.M., Acali S., Filocamo G., Traboni C., Nicosia A., Cortese R., Vitelli A. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 2002, 21:5017-5025.
50. Seeff L.B. Natural history of chronic hepatitis C. Hepatology 2002, 36(1):S35-S46.
51. Sharma N.R., Mateu G., Dreux M., Grakoui A., Cosset F.L., Melikyan G.B. Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion. J. Biol. Chem. 2011, 286:30361-30376.
52. Valiya Veettil M., Sadagopan S., Kerur N., Chakraborty S., Chandran B. Interaction of c-Cbl with myosin IIA regulates Bleb associated macropinocytosis of Kaposi's sarcoma-associated herpesvirus. PLoS Pathog. 2010, 6:e1001238.
53. Woodham A.W., Da Silva D.M., Skeate J.G., Raff A.B., Ambroso M.R., Brand H.E., Isas J.M., Langen R., Kast W.M. The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection. PLoS ONE 2012, 7:e43519.
54. Yamauchi Y., Helenius A. Virus entry at a glance. J. Cell Sci. 2013, 126:1289-1295.
55. Zhang X., Azhar G., Zhong Y., Wei J.Y. Identification of a novel serum response factor cofactor in cardiac gene regulation. J. Biol. Chem. 2004, 279:55626-55632.
56. Zhang X., Azhar G., Rogers S.C., Foster S.R., Luo S., Wei J.Y. Overexpression of p49/STRAP alters cellular cytoskeletal structure and gross anatomy in mice. BMC Cell Biol. 2014, 15:32.
57. Zona L., Lupberger J., Sidahmed-Adrar N., Thumann C., Harris H.J., Barnes A., Florentin J., Tawar R.G., Xiao F., Turek M., et al. HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex. Cell Host Microbe 2013, 13:302-313.